⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 24, 2024The Journal of Clinical Endocrinology & MetabolismOpen Access

Molecular profiling of low-risk papillary thyroid carcinoma (mPTC) on active surveillance

View Full Paper

Ask AI

Bookmark

Share

Abstract

The active surveillance (AS) program for papillary thyroid carcinoma (≤ 1 cm) at low-risk (mPTC) showed a low percentage of progression.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ramone et al. (2024) studied this question.

synapsesocial.com/papers/68e5b027b6db643587549f0b https://doi.org/10.1210/clinem/dgae575

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancerRetrospective Study · 2022 · 20 citations
2CHEK2 variant I157T may be associated with increased breast cancer riskCase-Control Study · 2004 · 163 citations
3BRAF (V600E) mutation analysis on liquid‐based cytology‐processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinomaCohort Study · 2012 · 118 citations
4Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease CourseOriginal Research · 2019 · 17 citations
5Can TP53-mutant follicular adenoma be a precursor of anaplastic thyroid carcinoma?Original Research · 2021 · 17 citations